UK’s largest medicinal cannabis report finds that half of the UK may be eligible for a prescription
50% of the UK may qualify for a medical cannabis prescription, yet only 0.48% of the population currently receive one
132 pieces for Volteface.
50% of the UK may qualify for a medical cannabis prescription, yet only 0.48% of the population currently receive one
This month, medicinal cannabis organisation Cancard announced a collaborative project with Grow Lab Organics to enable a licensed medicinal cannabis farm to…
Volteface Medical Cannabis on Prescription APPG appoints a new secretariat and with bold strategy and vision Featured
Are Germany's updated cannabis legalisation plans a step backwards? Paul and Katya discuss on Volteface TV....
Medical cannabis is legal in the UK, but most people still don't know how to access a prescription legally.
Why has the UK government announced plans to make nitrous oxide a Class C drug? Is NOS illegal?
The UPA medical cannabis patient group returns after a hiatus and will be meeting at the Brighton Medicinal Cannabis Summit 2023.
The UK’s largest medical cannabis company Lyphe Group has announced a new capital raise and the completion of an internal restructure.
Drug Science and MedCan Support launch a digital study with company Alta Flora on treatment resistant childhood epilepsy and medical cannabis
I am an opioid user, or a former one anyhow. Contrary to the cliche, I’m not addicted. I never felt trapped or enslaved by my drug use. I never…
In this episode Paul, Katya and George break down all the big talking points over the past month in the world of cannabis and drug reform. Topics covered…
The government has released a new drug strategy, in this piece we explore some of the good, the bad, and the somewhat ugly proposals.
Leading medical cannabis provider Grow Group Plc has been raising on the crowdfunding platform Seedrs throughout August. So far they’ve had over 500 new…
Decriminalising psychedelic drugs is undoubtedly an important step for social justice. However, there is a much larger issue that needs to be addressed for the…
The return of night life sadly comes with the return of increased drug-related harm. Over the weekend two young people died in Bristol and London from what is…
The Psychoactive Substances Act (PSA) was introduced in 2016, making the production or supply of any chemical substances that may be used for its psychoactive…
The Heroic Hearts Project UK (HHPUK) have this week announced a world-first observational study on the psychological and physiological effects of psilocybin on…
Volteface is delighted to welcome Tara O’Reilly as Head of Public Affairs to the team. Tara brings an exceptional amount of experience from her variety of roles…
It is rare, but it does happen: sometimes – just sometimes – life imitates art. This happened last night, when Coronation Street aired an episode – its 8,838th…
The inexorable momentum towards cannabis legalisation has taken hold across the globe. New, courageous policies are emerging in all corners of the earth – from…
This article was originally published on The Conversation. The latest spate of drug overdoses in Queensland has fulfilled the predictions of many health experts…
“Any questions?” I ask, as I conclude a one hour drug awareness session to a packed sixth form common room. The projector next to me is beaming a POV…
On Monday, VolteFace will publish our first policy paper, The Tide Effect, in collaboration with the Adam Smith Institute. The Tide Effect presents cannabis law…
Although the French accused the Germans of smuggling cocaine in order to deliberately weaken the French race, it was in Britain that the truly nationwide drug…